Results 241 to 250 of about 318,750 (310)

RAS P21 Protein Activator 3 finetunes Type I immunity by limiting HCK-mediated STAT4 phosphorylation. [PDF]

Nat Commun
Song J, Liu X, Sun J, Cheng X, He C, Zhong Y, Zhang J, Zhang J, Xiong H, Wu B.   +9 more
europepmc   +1 more source

Advancing Therapies for Mycobacterial Diseases: From Small Molecules to Host‐Directed Strategies

Medicinal Research Reviews, EarlyView.
ABSTRACT The global burden of multidrug‐resistant tuberculosis (MDR‐TB) and the rising incidence of nontuberculous mycobacterial (NTM) infections highlight the urgent need for innovative therapeutic strategies. Current treatments are prolonged, toxic, and increasingly compromised by resistance and limited diagnostic capacity.
Tânia Silva, Alessandra Aiello, Tonino Alonzi, M. Alice Carvalho, Vladimir Finger, Delia Goletti, Sven Hoffner, Yousra Kherabi, Jan Korabecny, Julia Kulczyńska, Agnieszka Kyzioł, Alicia Lacoma, Filomena Martins, Zorica Nanovic, Sepideh Hosseiniporgham, Martina Hrast Rambaher, Leonardo Antonio Sechi, Daria Smalchuk, Grażyna Stochel, Lydia Tabernero, Nancy L. Tateosian, Violeta Valcheva, Anamarija Zega, Mafalda Sarraguça   +23 more
wiley   +1 more source

Correction: Immunological impact of tumor-draining lymph node dissection on systemic Th1-like CD4⁺ T cells in patients with early-stage lung cancer. [PDF]

Cancer Immunol Immunother
Kamigaichi A, Kagamu H, Miyata Y, Mimae T, Tsubokawa N, Hirano K, Okada M.   +6 more
europepmc   +1 more source

<i>Helicobacter pylori</i> vaccines: from bench to bedside-progress, challenges, and future directions. [PDF]

Front Immunol
Wang S, Yang Y, Ma C, Guo L.
europepmc   +1 more source

Stem-like CD4 T cells in tumors: an emerging framework for antitumor immunity. [PDF]

Front Immunol
Xu J, Yang Y, Zhang J, Zhang Y.
europepmc   +1 more source

Depressed inflammatory mediators may suggest immunologic dysregulation in advanced venous disease. [PDF]

J Vasc Surg Venous Lymphat Disord
Franklin B, Xie B, Assaf E, Vodovotz L, Zhang Y, Chaer R, Sachdev U.   +6 more
europepmc   +1 more source

Uridine and pyruvate supplementation is associated with Th1 polarization during mitotoxic antibiotic therapy. [PDF]

iScience
De Santis S, Rutigliano M, Simone F, Larocca L, Matrella ML, Milella M, Vavallo A, Ditonno P, Marrano N, Mestice A, Battaglia S, Battaglia M, Moschetta A, Seibel P, Piccinin E, Villani G.   +15 more
europepmc   +1 more source

Cell-based therapies for malignant glioma. [PDF]

Stem Cells Transl Med
Mooney R, Abd El-Fattah EE, Ngai G, Lara J, Hammad M, Aboody KS.   +5 more
europepmc   +1 more source